|
- Human-Animal Chimeras Are Gestating on US Research Farms, MIT Technology Review
- High-Fidelity CRISPR-Cas9 Nucleases With No Detectable Genome-Wide Off-Target Effects, Nature
- Researchers Rein In Slice-Happy Gene Editor, CRISPR, Science Magazine
- California Stem Cell Agency Plots a Race to the Clinic, Science Magazine
- In Vivo Genome Editing Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy, Science Magazine
- Seize the World / Yamanaka: Prioritize Patients Above Papers, The Japan News
- Ethics of ART Interruption After Stem-Cell Transplantation, The Lancet HIV
- Gene Editing Offers Hope for Treating Duchenne Muscular Dystrophy, Studies Find, New York Times
- Stem Cells Help Evaluate Experimental Alzheimer’s Drugs, The Wall Street Journal
- Cartilage Growing to Rebuild Body Parts 'Within Three Years', BBC News
- The CRISPR Patent Interference Showdown is On: How Did We Get Here and What Comes Next?, Stanford Law and Sciences Blog
- An Arcane Patent Law May Decide Crispr’s Big Legal Fight, WIRED
- A Startup that Wants to Start Using a Controversial Gene-Editing Tool in People by 2017 Just Filed to Go Public, Business Insider
- Gene Editing Tool Hailed as a Breakthrough, And it Really is One, NPR
- These Are Some of the Crazy Things Scientists Did Using Gene Editing in 2015, Business Insider
- Credit for CRISPR: A Conversation with George Church, The Scientist
- Ethical Acceptability of Research on Human-Animal Chimeric Embryos: Summary of Opinions by the Japanese Expert Panel on Bioethics, Life Sciences, Society, and Policy
- A Win for Diabetes: Scientists Make Functional Pancreatic Cells from Skin, The Stem Cellar
- Top 10 Stem Cell Stories of the Year 2015, Knoepfler Lab Stem Cell Blog
- A New Vaccine Could Make Stem Cell Transplants Safer, The Stem Cellar
|
|
|
|
|